What is Zacks Research's Forecast for PAHC FY2025 Earnings?

Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) - Stock analysts at Zacks Research boosted their FY2025 earnings per share estimates for shares of Phibro Animal Health in a research note issued to investors on Wednesday, May 21st. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $2.02 for the year, up from their prior forecast of $1.92. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health's Q1 2026 earnings at $0.31 EPS, Q2 2026 earnings at $0.58 EPS, Q3 2026 earnings at $0.59 EPS, Q4 2026 earnings at $0.68 EPS, FY2026 earnings at $2.16 EPS and Q1 2027 earnings at $0.53 EPS.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.52 by $0.11. The company had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%.

A number of other research firms also recently weighed in on PAHC. Barclays raised their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research note on Monday, February 10th. Morgan Stanley raised their target price on shares of Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a research report on Thursday, May 8th. Finally, Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat.com, Phibro Animal Health has a consensus rating of "Hold" and a consensus price target of $20.00.

Phibro Animal Health Price Performance

NASDAQ:PAHC traded down $0.40 during trading hours on Friday, hitting $24.07. The company's stock had a trading volume of 167,367 shares, compared to its average volume of 199,414. Phibro Animal Health has a twelve month low of $16.16 and a twelve month high of $26.55. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The stock has a fifty day simple moving average of $20.36 and a 200-day simple moving average of $21.89. The company has a market capitalization of $975.45 million, a P/E ratio of 50.14, a PEG ratio of 0.45 and a beta of 0.62.

Hedge Funds Weigh In On Phibro Animal Health

Large investors have recently modified their holdings of the business. Nuveen LLC bought a new stake in shares of Phibro Animal Health in the first quarter worth $10,312,000. Invesco Ltd. lifted its holdings in Phibro Animal Health by 92.3% during the 1st quarter. Invesco Ltd. now owns 387,739 shares of the company's stock worth $8,282,000 after buying an additional 186,087 shares during the period. Axecap Investments LLC acquired a new stake in shares of Phibro Animal Health in the first quarter valued at about $3,696,000. Millennium Management LLC raised its position in shares of Phibro Animal Health by 74.3% during the first quarter. Millennium Management LLC now owns 362,030 shares of the company's stock worth $7,733,000 after acquiring an additional 154,281 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. lifted its stake in shares of Phibro Animal Health by 56.7% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company's stock worth $6,325,000 after acquiring an additional 108,918 shares during the period. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th will be given a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 1.99%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio (DPR) is currently 61.54%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.